Riverview Trust Co
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1593600
VANCOUVER, WA
Position in REGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,741
-$894 QoQ
Shares Held
6
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,270
of 1,322 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Riverview Trust Co holds $3,741 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
6 | $3,741 |
All Filings in REGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,741 | 6 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $4,635 | 6 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $4,631 | 6 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $3,373 | 6 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,150 | 6 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $54,543 | 86 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $61,260 | 86 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $115,636 | 110 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $113,511 | 108 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $71,224 | 74 | Shares | Sole | 2024-04-12 | |
| 2023-09-30 | $60,899 | 74 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $53,171 | 74 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $60,803 | 74 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $53,390 | 74 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $50,976 | 74 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $43,743 | 74 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $51,683 | 74 | Shares | Sole | 2022-04-21 | |
| No filing history on record for this holder in this stock. | ||||||